Abstract:DNA damage is a key factor both in the evolution and treatment of cancer Genomic instability is a common feature of cancer cells, fuelling accumulation of oncogenic mutations while radiation and diverse genotoxic agents remain important, if Imperfect, therapeutic modalities Cellular responses to DNA damage are coordinated primarily by two distinct kinase signaling cascades, the ATM-Chk2 and ATR-Chk1 pathways, which are activated by DNA double strand breaks (DSBs) and single stranded DNA respectively Historically these pathways were thought to act in parallel with overlapping functions, however, more recently It has become apparent that their relationship is more complex In response to DSBs, ATM is required both for ATR-Chk1 activation and to inmate DNA repair via homologous recombination (HRR) by promoting formation of single stranded DNA at sites of damage through nucleolytic resection Interestingly cells and organisms survive with mutations in ATM or other components required for HRR, such as BRCA1 and BRCA2 but at the cost of genomic instability and cancer predisposition By contrast the ATR-Chk1 pathway is the principal direct effector of the DNA damage and replication checkpoints and, as such, is essential for the survival of many, although not all, cell types Remarkably, deficiency for HRR in BRCA1 and BRCA2 deficient tumors confers sensitivity to cisplatin and inhibitors of poly(ADP ribose) polymerase (PARP), an enzyme required for repair of endogenous DNA damage In addition, suppressing DNA damage and replication checkpoint responses by inhibiting Chk1 can enhance tumor cell killing by diverse genotoxic agents Here, we review current understanding of the organization and functions of the ATM-Chk2 and ATR-Chk1 pathways and the prospects for targeting DNA damage signaling processes for therapeutic purposes (C) 2010 Elsevier Inc

The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway

Phosphorylation of Daxx by Atm Contributes to Dna Damage-Induced P53 Activation

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage

Oligomerization of MDC1 Protein Is Important for Proper DNA Damage Response

ATM-mediated KDM2A Phosphorylation is Required for the DNA Damage Repair

Interplay Between Mdm2 And Hipk2 In The Dna Damage Response

Tip60: Connecting Chromatin to DNA Damage Signaling.

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities

Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.

Reversal of the ATM/ATR-mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D.

Chfr and RNF8 Synergistically Regulate ATM Activation

ATM and ATR：Sensing DNA Damage

Atm Kinase is A Master Switch for the Delta Np63 Alpha Phosphorylation/Degradation in Human Head and Neck Squamous Cell Carcinoma Cells Upon Dna Damage

Mechanistic Links Between ATM and Histone Methylation Codes During DNA Repair.

Beyond the Trinity of ATM, ATR, and DNA-PK: Multiple Kinases Shape the DNA Damage Response in Concert With RNA Metabolism

Regulation of DNA Damage-Induced ATM Activation by Histone Modifications

Homeostatic Regulation of Base Excision Repair by A P53-Induced Phosphatase - Linking Stress Response Pathways with Dna Repair Proteins

MTA1 Coregulator Regulates P53 Stability and Function

The Activation Mechanisms of Master Kinases in the DNA Damage Response

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.